Anorexia Nervosa – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report

Anorexia nervosa is an eating disorder characterized by a severe restriction of calorie intake leading to dangerously low body weight, which is influenced by various factors, including societal pressures on body image. Biological and environmental factors both contribute to the development of anorexia nervosa, with genetic links observed between traits like educational attainment, neuroticism, and schizophrenia. Individuals suffering from anorexia nervosa often exhibit changes in both brain function and structure, including deficiencies in neurotransmitters such as dopamine, which impacts eating behavior and the sensation of reward, and serotonin, affecting impulse control and levels of neuroticism. Furthermore, there is evidence of altered activation patterns within the corticolimbic system, influencing appetite and responses to fear, and reduced activity in frontostriatal circuits regulating habitual behaviours. Additionally, patients frequently present with comorbid psychiatric conditions like major depressive disorder and generalized anxiety disorder. Treatment typically involves a combination of nutritional rehabilitation and psychotherapy, with pharmacotherapy usually reserved for cases where initial interventions prove ineffective. Olanzapine is commonly used as a first-line medication for acutely ill patients who do not respond adequately to initial treatment.

Thelansis’s “Anorexia Nervosa Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Anorexia Nervosa treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Anorexia Nervosa across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Anorexia Nervosa Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Read more: Anorexia Nervosa – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Tags: Anorexia Nervosa, Anorexia Nervosa market outlook, Anorexia Nervosa competitive landscape, Anorexia Nervosa market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)